Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease

References

• Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:2137–42.
   PubMed Web of Science ®Google Scholar
• Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101:2857–65.
   PubMed Web of Science ®Google Scholar
• Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn's and Colitis 2009;2:47–91.
   Google Scholar
• Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV. Review, Part 1: human herpesvirus-6 — Basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 2010;82:1560–8.
   PubMed Web of Science ®Google Scholar
• Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065–7.
   PubMed Web of Science ®Google Scholar
• Lautenschlager I, Linnavuori K, Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 2000;69:2561–6.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Singh N. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 2006;37:S87-91.
   Web of Science ®Google Scholar
• Razonable RR, Zerr DM. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant 2009;9:S97-103.
   PubMed Web of Science ®Google Scholar
• Vinnard C, Barton T, Jerud E, Blumberg E. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl 2009;15:1242–6.
   PubMed Web of Science ®Google Scholar
• Amo K, Tanaka-Taya K, Inagi R, Miyagawa H, Miyoshi H, Okusu I, Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis 2003;36:120–3.
   PubMed Web of Science ®Google Scholar
• Hentrich M, Oruzio D, Jager G, Schlemmer M, Schleuning M, Schiel X, Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005;128:66–72.
   PubMed Web of Science ®Google Scholar
• Halme L, Arola J, Hockerstedt K, Lautenschlager I. Human herpesvirus 6 infection of the gastroduodenal mucosa. Clin Infect Dis 2008;46:434–9.
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Fox JD, Sawyerr AM, Taylor JE, Sweenie CH, Smith M, Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992;38:183–90.
   PubMed Web of Science ®Google Scholar
• Lavagna A, Bergallo M, Daperno M, Sostegni R, Costa C, Leto R, Infliximab and the risk of latent viruses reactivation in active Crohn's disease. Inflamm Bowel Dis 2007;13:896–902.
   PubMed Web of Science ®Google Scholar
• D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763–86.
   PubMed Web of Science ®Google Scholar
• Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505–12.
   PubMed Web of Science ®Google Scholar
• Moskovitz DN, Daperno M, Van Assche G. Defining and validating cut-offs for the Simple Endocopic Score for Crohn's Disease. Gastroenterology 2007;132:S1097.
   Web of Science ®Google Scholar
• Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean? Gut 1991;32:174–8.
   PubMed Web of Science ®Google Scholar
• Halme L, Höckerstedt K, Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003;75:1853–8.
   PubMed Web of Science ®Google Scholar
• Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998;26:702–7.
   PubMed Web of Science ®Google Scholar
• The TH, van den Berg AP, Harmsen MC, van der Bij W, van Son WJ. The cytomegalovirus antigenemia assay: A plea for standardization. Scand J Infect Dis 1995;99:25–9.
   Google Scholar
• Nakase H, Matsumura K, Yoshino T, Chiba T. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2008;43:735–40.
   PubMed Web of Science ®Google Scholar
• Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander. Inflamm Bowel Dis. 2010;16:1620–7.
   PubMed Web of Science ®Google Scholar
• Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci 2009;54:2456–62.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007;13:1516–21.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Simpson N, Klipfel N. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010;55:1059–65.
   PubMed Web of Science ®Google Scholar
• Nakase H, Yoshino T, Honzawa Y, Chiba T. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci 2010;55:1498–9.
   PubMed Web of Science ®Google Scholar
• Lempinen M, Halme L, Sarkio S, Arola J, Honkanen E, Turunen U, CMV findings in the gastrointestinal tract in kidney transplantation patients, patients with end-stage kidney disease and immunocompetent patients. Nephrol Dial Transplant 2009;24:3533–9.
   PubMed Web of Science ®Google Scholar
• Shale MJ. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. Br Med Bull 2009;92:61–77.
   PubMed Web of Science ®Google Scholar
• Criscuoli V, Mocciaro F, Orlando A, Rizzuto MR, Renda MC, Cottone M. Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis. Inflamm Bowel Dis 2009;15:810–11.
   PubMed Web of Science ®Google Scholar
• Torre-Cisneros J. Del Castillo M. Castón JJ. Castro MC. Pérez V. Collantes E. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. Rheumatology 2005;44:1132–5.
   PubMed Web of Science ®Google Scholar
• Helbling D, Breitbach TH, Krause M. Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol 2002;14:1393–5.
   PubMed Web of Science ®Google Scholar
• D'Ovidio V, Vernia P, Gentile G, Capobianchi A, Marcheggiano A, Viscido A, Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008;43:180–3.
   PubMed Web of Science ®Google Scholar
• Knosel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract 2009;205:223–30.
   PubMed Web of Science ®Google Scholar
• Sura R, Gavrilov B, Flamand L, Ablashi D, Cartun R, Colombel JF, Human herpesvirus-6 in patients with Crohn's disease. APMIS 2010;118:394–400.
   PubMed Web of Science ®Google Scholar
• Halme L, Lempinen M, Arola J, Sarkio S, Höckerstedt K, Lautenschlager I. High frequency of gastroduodenal cytomegalovirus infection in liver transplant patients. APMIS 2008;116:99–106.
   PubMed Web of Science ®Google Scholar
• Mendez JC, Dockrell DH, Espy MJ, Smith TF, Wilson JA, Harmsen WS, Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 2001;183:179–84.
   PubMed Web of Science ®Google Scholar
• DesJardin JA, Gibbons L, Cho E, Supran SE, Falagas ME, Werner BG, Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998;178:1783–6.
   PubMed Web of Science ®Google Scholar
• Petrisli E, Chiereghin A, Gabrielli L, Zanfi C, Lauro A, Piccirilli G, Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. Transplant Proc 2010;42:74–8.
   PubMed Web of Science ®Google Scholar
• Streetz KL. Buhr T. Wedemeyer H. Bleck J. Schedel I. Manns MP. Göke MN. Acute CMV-colitis in a patient with a history of ulcerative colitis. Scand J Gastroenterol 2003;38:119–22.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Sterringa G, Van Deventer SJ, Tytgat GN, Weel J. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004;10:245–50.
   PubMed Web of Science ®Google Scholar